EUVIMEDEUVIMED entdecken
Crossref

Pharmacokinetics, Tissue Distribution, and Excretion of 9‐Methylfascaplysin, a Potential Anti‐Alzheimer's Disease Agent

Manman Zhang, Yu Xu, Xingjian Sun, Xiaolu Shi, Hongze Liang, Xiaowei Chen, Wei Cui, Yilei Fan, Jianfeng Ma, Haixing Wang

ELECTROPHORESIS · 2025

DOI: 10.1002/elps.8135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ELECTROPHORESIS, 2025. Verfasst von Manman Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Rehabilitation Medicine, Department of Neurology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical Co…. Hauptthemen laut MEDLINE: Alzheimer Disease, Quaternary Ammonium Compounds, Indolizines, Carbolines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Zhejiang Provincial Key Research and Development Program, Wenzhou Science and Technology Project, Research Fund of National Narcotics Laboratory Zhejiang Regional Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

9‐Methylfascaplysin, a derivative of the marine natural product fascaplysin, has shown promising anti‐ Alzheimer's disease (AD) potential through its anti‐β‐amyloid (Aβ) neuroprotective effects. However, the pharmacokinetics (PK) of 9‐methylfascaplysin, crucial for its preclinical evaluation, have not been thoroughly studied. In this study, we developed and validated a sensitive and accurate ultra‐performance liquid chromatography‐tandem mass spectrometry (UPLC‐MS/MS) method for the quantification of 9‐methylfascaplysin in rat plasma. The method demonstrated a lower limit of detection (LLOD) of 1 ng/mL and a linear quantification range of 5–2000 ng/mL. The PK study in rat plasma was conducted. After intragastric administration, the plasma concentration of 9‐methylfascaplysin peaked at a maximum concentration ( C max ) of 193.4 ng/m and an enterohepatic circulation (EHC) phenomenon was observed. By comparing the area under the plasma concentration‐time curve (AUC) values obtained from intragastric and intravenous administrations, the absolute oral bioavailability (F) of 9‐methylfascaplysin was determined as 18.3%. The tissue distribution study revealed that following a single intragastric administration, 9‐methylfascaplysin was most concentrated in the stomach, followed by the small intestine, large intestine, liver, kidney, brain, lung, spleen, and heart in descending order. Furthermore, the excretion profiles of 9‐methylfascaplysin in rat urine and feces were studied. The results of this study provide valuable insights into the PK behavior of 9‐methylfascaplysin and serve as a foundation for its further preclinical evaluation and potential clinical application as an anti‐AD agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseQuaternary Ammonium CompoundsIndolizinesCarbolinesIndolesAnimalsMaleRatsChromatography, High Pressure LiquidFecesLimit of DetectionLinear ModelsRats, Sprague-DawleyReproducibility of ResultsTandem Mass SpectrometryTissue Distribution

Stichwörter der Autor:innen

9‐methylfascaplysinUPLC‐MS/MSpharmacokineticsrat plasmatissue distribution

Substanzen

fascaplysineQuaternary Ammonium CompoundsIndolizinesCarbolinesIndoles

Autor:innen und Institutionen

  • Center for Rehabilitation Medicine, Department of Neurology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.
  • Key Laboratory of Drug Monitoring and Control of Zhejiang Province, National Narcotics Laboratory Zhejiang Regional Center, Hangzhou, China.
  • School of Mathematical Sciences, Zhejiang University, Hangzhou, China.
  • School of Materials Science and Chemical Engineering, Ningbo University, Ningbo, China.
  • Ningbo Key Laboratory of Behavioral Neuroscience, Zhejiang Provincial Key Laboratory of Pathophysiology, School of Medicine, Ningbo University, Ningbo, China.
  • The Department of Criminal Science and Technology, Zhejiang Police College, Hangzhou, China.

Förderung

  • Zhejiang Provincial Key Research and Development Program
  • Wenzhou Science and Technology Project
  • Research Fund of National Narcotics Laboratory Zhejiang Regional Center

Zitieren

APA

Zhang, M., Xu, Y., Sun, X., Shi, X., Liang, H., Chen, X., Cui, W., Fan, Y., Ma, J., & Wang, H. (2025). Pharmacokinetics, Tissue Distribution, and Excretion of 9‐Methylfascaplysin, a Potential Anti‐Alzheimer's Disease Agent. ELECTROPHORESIS. https://doi.org/10.1002/elps.8135

Vancouver

Zhang M, Xu Y, Sun X, Shi X, Liang H, Chen X, et al. Pharmacokinetics, Tissue Distribution, and Excretion of 9‐Methylfascaplysin, a Potential Anti‐Alzheimer's Disease Agent. ELECTROPHORESIS. 2025. doi:10.1002/elps.8135

BibTeX
@article{Zhang2025,
  author = {Zhang, Manman and Xu, Yu and Sun, Xingjian and Shi, Xiaolu and Liang, Hongze and Chen, Xiaowei and Cui, Wei and Fan, Yilei and Ma, Jianfeng and Wang, Haixing},
  title = {Pharmacokinetics, Tissue Distribution, and Excretion of 9‐Methylfascaplysin, a Potential Anti‐Alzheimer's Disease Agent},
  journal = {ELECTROPHORESIS},
  year = {2025},
  doi = {10.1002/elps.8135}
}
Kostenlos starten →